Daizo Kaito
Gifu-shi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Effect of Mirtazapine for the Prevention of Nausea and Vomiting in Patients With Thoracic Cancer Receiving Platinum-based Chemotherapy.
Journal: Anticancer research
Published: January 18, 2023
Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer.
Journal: Molecular and clinical oncology
Published: November 19, 2021
Efficacy of cisplatin plus vinorelbine adjuvant chemotherapy with split-dose administration of cisplatin after complete resection of stage II-IIIA non-small cell lung cancer.
Journal: Molecular and clinical oncology
Published: November 14, 2021
Primary Prophylaxis of Febrile Neutropenia With Pegfilgrastim in Small-cell Lung Cancer Patients Receiving Amrubicin as Second-line Therapy.
Journal: Anticancer research
Published: November 19, 2020
Low-Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin-Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial.
Journal: The oncologist
Published: October 30, 2020
Prophylactic effect of rikkunshito, an herbal medicine, for chemotherapy-induced nausea in thoracic cancer patients receiving carboplatin-based chemotherapy.
Journal: Die Pharmazie
Published: November 06, 2019
Evaluation of clinical pharmacist interventions for adverse events in hospitalized patients with thoracic cancer receiving cancer chemotherapy.
Journal: Molecular and clinical oncology
Published: August 12, 2019
Effects of pharmacokinetics-related genetic polymorphisms on the side effect profile of afatinib in patients with non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 12, 2019
Immune thrombocytopenia induced by nivolumab in a patient with non-small cell lung cancer.
Journal: Respiratory medicine case reports
Published: March 24, 2019
Efficacy of Single-dose First-generation 5-HT3 Receptor Antagonist and Dexamethasone for Preventing Nausea and Vomiting Induced by Low-dose Carboplatin-based Chemotherapy.
Journal: Anticancer research
Published: January 20, 2017
Pharmacokinetics of consecutive oral moxifloxacin (400 mg/day) in patients with respiratory tract infection.
Journal: Therapeutic advances in respiratory disease
Published: December 15, 2015
Last Updated: 09/26/2026